Immune interactions in hepatic fibrosis.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMC 2605646)

Published in Clin Liver Dis on November 01, 2008

Authors

Andrew P Holt1, Mike Salmon, Christopher D Buckley, David H Adams

Author Affiliations

1: Liver Research Group, MRC Centre for Immune Regulation, University of Birmingham, Birmingham, UK.

Articles citing this

Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J Clin Invest (2010) 2.87

Mechanisms of immune-mediated liver injury. Toxicol Sci (2010) 1.48

Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am J Physiol Gastrointest Liver Physiol (2011) 1.44

Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression. Hepatology (2012) 1.24

Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology (2010) 1.20

The role of stem cells in liver repair and fibrosis. Int J Biochem Cell Biol (2009) 1.09

Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair (2010) 1.09

Inhibition of TNF-α-mediated NF-κB Transcriptional Activity in HepG2 Cells by Dammarane-type Saponins from Panax ginseng Leaves. J Ginseng Res (2012) 1.04

Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice. Gut (2014) 1.03

Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci (2014) 1.00

From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms. Genome Med (2012) 0.93

Liver Injury and the Activation of the Hepatic Myofibroblasts. Curr Pathobiol Rep (2013) 0.89

The chemokine CCL3 promotes experimental liver fibrosis in mice. PLoS One (2013) 0.87

Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression. Int J Clin Exp Pathol (2013) 0.84

Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines. World J Gastroenterol (2015) 0.83

Interference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injury. PLoS One (2012) 0.82

Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion. Gut Liver (2016) 0.82

Explore the Molecular Mechanism of Apoptosis Induced by Tanshinone IIA on Activated Rat Hepatic Stellate Cells. Evid Based Complement Alternat Med (2012) 0.81

Role of adaptive immunity in alcoholic liver disease. Int J Hepatol (2011) 0.81

Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice. BMC Syst Biol (2015) 0.77

Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study. J Gastroenterol (2010) 0.77

Ionone Derivatives from the Mycelium of Phellinus linteus and the Inhibitory Effect on Activated Rat Hepatic Stellate Cells. Int J Mol Sci (2016) 0.75

Activated rat hepatic stellate cells influence Th1/Th2 profile in vitro. World J Gastroenterol (2015) 0.75

Th17 down-regulation is involved in reduced progression of schistosomiasis fibrosis in ICOSL KO mice. PLoS Negl Trop Dis (2015) 0.75

Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis. PLoS One (2017) 0.75

Platelets: No longer bystanders in liver disease. Hepatology (2016) 0.75

Articles cited by this

(truncated to the top 100)

Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36

Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 21.56

Liver fibrosis. J Clin Invest (2005) 17.27

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med (1997) 14.51

T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature (2004) 11.14

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem (2000) 9.07

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest (2005) 8.58

Endothelial/pericyte interactions. Circ Res (2005) 8.24

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest (2004) 7.91

Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol (2001) 7.40

Homing and cellular traffic in lymph nodes. Nat Rev Immunol (2003) 7.23

Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity (2006) 7.22

Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science (1996) 7.00

Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A (2002) 6.98

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest (1998) 5.27

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med (2005) 5.13

Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol (2000) 4.73

Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol (2003) 4.69

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest (2007) 4.41

IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature (2005) 4.31

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest (1999) 4.22

Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med (2000) 3.97

Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity (2007) 3.61

Hepatic T cells and liver tolerance. Nat Rev Immunol (2003) 3.51

A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology (2004) 3.42

Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol (2006) 3.42

Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res (2000) 3.27

Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol (2004) 3.25

Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol (2006) 3.15

Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol (2001) 3.08

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology (2006) 3.03

Enhancer-mediated control of macrophage-specific arginase I expression. J Immunol (2004) 2.95

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology (2000) 2.83

Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol (2002) 2.65

Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol (2007) 2.64

Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology (2004) 2.54

CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun (2006) 2.54

Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol (2003) 2.48

Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A (2006) 2.41

The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med (2002) 2.37

From fat to inflammation. Gastroenterology (2006) 2.35

Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis (2001) 2.35

Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis (2001) 2.32

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med (2007) 2.32

Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest (1995) 2.29

Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest (2007) 2.28

Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol (2000) 2.18

Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol (2000) 2.16

Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology (1999) 2.07

A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest (1997) 2.04

An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med (2006) 2.00

Cytokines and fibrogenesis. Semin Liver Dis (1999) 1.96

Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood (2002) 1.92

IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J Immunol (1999) 1.91

A stromal address code defined by fibroblasts. Trends Immunol (2005) 1.90

Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol (2001) 1.89

Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol (1999) 1.87

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol (2006) 1.86

Attenuated liver fibrosis in the absence of B cells. J Clin Invest (2005) 1.82

C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol (1995) 1.80

The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep (2006) 1.78

Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond) (2007) 1.77

Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab (2002) 1.74

Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol (2006) 1.71

Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am J Pathol (2000) 1.71

Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology (2003) 1.69

The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology (2003) 1.64

Liver fibrosis: from the bench to clinical targets. Dig Liver Dis (2004) 1.58

B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1. J Immunol (2003) 1.56

Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J (2002) 1.56

Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol (2002) 1.55

Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb Haemost (2003) 1.55

Signal transduction in hepatic stellate cells. Liver (1998) 1.55

Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest (1993) 1.54

Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol (2005) 1.53

RelB regulation of chemokine expression modulates local inflammation. Am J Pathol (1997) 1.50

CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol (2005) 1.49

Recruitment of lymphocytes to the human liver. Immunol Cell Biol (2002) 1.49

Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology (2005) 1.46

Bystander virus infection prolongs activated T cell survival. J Immunol (1999) 1.43

Follicular dendritic cells are related to bone marrow stromal cell progenitors and to myofibroblasts. J Immunol (2006) 1.43

CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection. J Exp Med (1999) 1.39

Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology (1996) 1.35

Lymphocyte-hepatic stellate cell proximity suggests a direct interaction. Clin Exp Immunol (2007) 1.35

A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation. J Exp Med (1997) 1.34

Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology (2008) 1.30

Hepatic stellate cells and the regulation of liver inflammation. J Hepatol (1999) 1.30

Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. FASEB J (2001) 1.30

CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol (2005) 1.30

Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology (2005) 1.28

Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc Natl Acad Sci U S A (1994) 1.25

Cutting edge: the development of IL-4-producing B cells (B effector 2 cells) is controlled by IL-4, IL-4 receptor alpha, and Th2 cells. J Immunol (2005) 1.22

Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum (2000) 1.22

Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum (2006) 1.20

Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol (2002) 1.19

Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis. J Clin Invest (2005) 1.19

Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am J Pathol (1999) 1.18

Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol (1994) 1.15

Transforming growth factor-beta induces human T lymphocyte migration in vitro. J Immunol (1991) 1.15

Articles by these authors

Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science (2006) 5.31

Resolution of inflammation: state of the art, definitions and terms. FASEB J (2007) 5.12

Bayesian variable selection in multinomial probit models to identify molecular signatures of disease stage. Biometrics (2004) 4.71

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells. Nat Med (2012) 4.38

A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood (2009) 3.63

Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther (2005) 3.17

Aortic valve surgery after previous coronary artery bypass grafting with functioning internal mammary artery grafts. Ann Thorac Surg (2002) 2.88

Results and predictors of early and late outcomes of coronary artery bypass graft surgery in octogenarians. J Cardiothorac Vasc Anesth (2007) 2.73

Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol (2003) 2.67

Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology (2008) 2.43

EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology (2010) 2.37

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med (2007) 2.32

A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry (2006) 2.28

Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol (2005) 2.28

The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Ann Rheum Dis (2013) 2.28

Integrated thoracic residency program applicants: the best and the brightest? Ann Thorac Surg (2011) 2.22

Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A (2010) 2.19

Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol (2002) 2.18

Bilateral internal mammary artery grafts, mortality and morbidity: an analysis of 1 526 360 coronary bypass operations. Heart (2013) 2.15

Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol (2009) 2.14

The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease. Gastroenterology (2002) 2.12

Management of systolic anterior motion after mitral valve repair: an algorithm. J Thorac Cardiovasc Surg (2012) 2.07

Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04

Cardiac myxoma: preoperative diagnosis using a multimodal imaging approach and surgical outcome in a large contemporary series. Interact Cardiovasc Thorac Surg (2007) 2.03

CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol (2007) 1.99

Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett (2005) 1.96

Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann Rheum Dis (2011) 1.96

CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver. J Hepatol (2012) 1.95

A stromal address code defined by fibroblasts. Trends Immunol (2005) 1.90

Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica (2008) 1.87

Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol (2005) 1.85

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2011) 1.83

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology (2010) 1.82

Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation (2009) 1.78

A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians. Eur Heart J (2010) 1.78

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis (2012) 1.78

Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76

A three-dimensional ring annuloplasty for the treatment of tricuspid regurgitation. Ann Thorac Surg (2006) 1.75

Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J Leukoc Biol (2005) 1.74

Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med (2004) 1.71

Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J Immunol (2010) 1.66

The intraoperative "ink test": a novel assessment tool in mitral valve repair. J Thorac Cardiovasc Surg (2007) 1.64

Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci (2005) 1.61

Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol (2010) 1.61

Incidence, topography, predictors and long-term survival after stroke in patients undergoing coronary artery bypass grafting. Ann Thorac Surg (2008) 1.60

Primary sclerosing cholangitis. Lancet (2013) 1.59

Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis. Ann Rheum Dis (2010) 1.59

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs. BMC Med (2005) 1.57

Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum (2003) 1.56

Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol (2002) 1.55

Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb Haemost (2003) 1.55

Inverted left atrial appendage. J Am Coll Cardiol (2009) 1.55

Predictors and early and late outcomes of dialysis-dependent patients in contemporary cardiac surgery. J Cardiothorac Vasc Anesth (2008) 1.54

Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J Clin Psychiatry (2009) 1.53

The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc Natl Acad Sci U S A (2009) 1.51

CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol (2005) 1.49

Recruitment of lymphocytes to the human liver. Immunol Cell Biol (2002) 1.49

Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication. Hepatology (2013) 1.47

Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum (2011) 1.46

Tracheostomy is not a risk factor for deep sternal wound infection after cardiac surgery. Ann Thorac Surg (2007) 1.46

The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J Clin Invest (2008) 1.46

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. Hepatology (2009) 1.46

Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology (2009) 1.46

Liberal use of delayed sternal closure for postcardiotomy hemodynamic instability. Ann Thorac Surg (2002) 1.45

Predictors and outcomes of seizures after cardiac surgery: a multivariable analysis of 2,578 patients. Ann Thorac Surg (2011) 1.45

Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation, Right Ventricular Function, and Pulmonary Artery Hypertension After Repair of Mitral Valve Prolapse. J Am Coll Cardiol (2015) 1.43

Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med (2004) 1.43

Excellent outcomes with use of synthetic vascular grafts for treatment of mycotic aortic pseudoaneurysms after heart transplantation. Ann Thorac Surg (2011) 1.42

A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol (2005) 1.41

Does prior coronary bypass surgery present a unique risk for reoperative valve surgery? Ann Thorac Surg (2013) 1.41

[Remodeling annuloplasty using a prosthetic ring designed for correcting type-IIIb ischemic mitral regurgitation]. Rev Esp Cardiol (2007) 1.41

Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J Immunol (2006) 1.40

Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology (2008) 1.39

Delays in assessment of patients with rheumatoid arthritis: variations across Europe. Ann Rheum Dis (2011) 1.39

Epidemiology of deep sternal wound infection in cardiac surgery. J Cardiothorac Vasc Anesth (2009) 1.38

The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol (2007) 1.38

LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology (2005) 1.37

A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium. Arthritis Rheum (2005) 1.36

Predictors and outcome of gastrointestinal complications in patients undergoing cardiac surgery. Ann Surg (2007) 1.35

Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One (2011) 1.34

Treating very early rheumatoid arthritis. Best Pract Res Clin Rheumatol (2006) 1.34

Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort. Ann Rheum Dis (2011) 1.34

EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging (2012) 1.33

Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med (2012) 1.32

Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg (2005) 1.31

Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci (2007) 1.30

CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol (2005) 1.30

Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood (2004) 1.30

Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells. Gastroenterology (2009) 1.29